Abstract
Background:Neonatal mortality and morbidity are increasingly recognized as important globally, but detailed estimates of neonatal morbidity from conditions and long-term consequences are yet to be published.Methods:We describe the general methods for systematic reviews, meta-analyses, and modeling used in this supplement, highlighting differences from the Global Burden of Disease (GBD2010) inputs and methods. For five conditions (preterm birth, retinopathy of prematurity, intrapartum-related conditions, neonatal infections, and neonatal jaundice), a standard three-step compartmental model was applied to estimate—by region, for 2010—the numbers of (i) affected births by sex, (ii) postneonatal survivors, and (iii) impaired postneonatal survivors. For conditions included in GBD2010 analyses (preterm birth and intrapartum-related conditions), impairment at all ages was estimated, and disability weights were applied to estimate years lived with disability (YLD) and summed with years of life lost (YLL) to calculate disability-adjusted life years (DALYs).Results:GBD2010 estimated neonatal conditions (preterm birth, intrapartum-related, neonatal sepsis, and “other neonatal”) to be responsible for 202 million DALYs or 8.1% (7.3–9.0%) of the worldwide total. Mortality contributed 95% of the DALYs, and the estimated 26% reduction in neonatal condition DALYs since 1990 is primarily due to a 44% reduction in neonatal mortality rate due to these conditions, counterbalanced by increased numbers of babies born (17%). Impairment following neonatal conditions remained stable globally and is therefore relatively more important, especially in high- and middle-income countries. Crucial data gaps were identified.Conclusion:These results confirm neonatal conditions as a significant burden, reemphasizing the need to reduce deaths further, to count the linked 2.6 million stillbirths, and to better measure and address their long-term effects.
Keywords
MeSH Terms
Affiliated Institutions
Related Publications
The global burden of rheumatoid arthritis: estimates from the Global Burden of Disease 2010 study
To estimate the global burden of rheumatoid arthritis (RA), as part of the Global Burden of Disease 2010 study of 291 conditions and how the burden of RA compares with other con...
The global burden of hip and knee osteoarthritis: estimates from the Global Burden of Disease 2010 study
To estimate the global burden of hip and knee osteoarthritis (OA) as part of the Global Burden of Disease 2010 study and to explore how the burden of hip and knee OA compares wi...
Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010
Although stroke is the second leading cause of death worldwide, no comprehensive and comparable assessment of incidence, prevalence, mortality, disability, and epidemiological t...
Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010
No systematic attempts have been made to estimate the global and regional prevalence of amphetamine, cannabis, cocaine, and opioid dependence, and quantify their burden. We aime...
Global numbers of infection and disease burden of soil transmitted helminth infections in 2010
Quantifying the burden of parasitic diseases in relation to other diseases and injuries requires reliable estimates of prevalence for each disease and an analytic framework with...
Publication Info
- Year
- 2013
- Type
- article
- Volume
- 74
- Issue
- S1
- Pages
- 4-16
- Citations
- 149
- Access
- Closed
External Links
Social Impact
Social media, news, blog, policy document mentions
Citation Metrics
Cite This
Identifiers
- DOI
- 10.1038/pr.2013.203
- PMID
- 24366460
- PMCID
- PMC3873708